XML 31 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Revision of Prior Period Financial Statements (Tables)
6 Months Ended
Jun. 30, 2021
Revision Of Prior Period Financial Statements [Abstract]  
Schedule of unaudited interim condensed financial statements
   As Previously
Reported
   Adjustments   As Restated 
Balance Sheet at December 23, 2020            
Common stock subject to possible redemption  $135,094,307   $4,285,693   $139,380,000 
Common stock   479    (42)   437 
Additional paid-in capital   5,007,859    (4,860,327)   147,532 
                
Balance Sheet at December 31, 2020               
Common stock subject to possible redemption  $134,983,359   $4,399,888   $139,383,247 
Common stock   480    (43)   437 
Additional paid-in capital   5,118,821    (4,974,521)   144,300 
Accumulated deficit  $(119,298)  $(6,184)  $(125,482)
                
Statement of Operations for the year ended December 31, 2020               
Basic and diluted weighted average shares outstanding, common stock subject to redemption   
-
    339,344    339,344 
Basic and diluted weighted average shares outstanding, common stock not subject to redemption   
-
    3,429,593    3,429,593 
Basic and diluted weighted average shares outstanding, common stock   4,198,081    (429,144)   3,768,937 
                
Statement of Cash Flows for the year ended December 31, 2020               
Supplemental disclosure of cash flow information               
Initial value of common stock subject to possible redemption  $135,094,307   $(11,621,066)  $123,473,241 
Change in value of common stock subject to possible redemption   (110,948)   110,948    
-
 
Reclassification of offering costs related to public shares   
-
    (2,946,021)   (2,946,021)
Subsequent measurement of common stock subject to redemption   
-
    18,852,780    18,852,780 
Subsequent measurement of common stock subject to redemption  (interest earned on trust account)  $
-
   $3,247   $3,247 
                
Balance Sheet at March 31, 2021               
Common stock subject to possible redemption  $134,522,628   $4,884,666   $139,407,294 
Common stock   485    (48)   437 
Additional paid-in capital   5,004,871    (4,884,618)   120,253 
Accumulated deficit  $(5,345)  $0   $(5,345)
                
Statement of Operations for the three months ended March 31, 2021               
Basic and diluted weighted average shares outstanding, common stock subject to redemption   
-
    13,800,000    13,800,000 
Basic and diluted weighted average shares outstanding, common stock not subject to redemption   
-
    4,369,000    4,369,000 
Basic and diluted weighted average shares outstanding, common stock   18,169,000    0    18,169,000 
                
Statement of Cash Flows for the three months ended March 31, 2021               
Supplemental disclosure of cash flow information               
Change in value of common stock subject to possible redemption  $120,140   $(120,140)  $
-
 
Subsequent measurement of common stock subject to redemption (interest earned on trust account)  $
-
   $24,047   $24,047